Gossamer Bio GOSS
NASDAQ GOSS
$0.16 -0.02 (-11.23%)
At close: Sep 9, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) EBT Margin (2024 - 2026)

Gossamer Bio (GOSS) posted EBT Margin of 308.63% for Q2 2026, down 10.71% on a QoQ basis from 278.78% in Q1 2026, and up 2450.0% year-over-year from 12.1% in Q2 2025.

Analysis

Gossamer Bio (GOSS) EBT Margin (2024 - 2026) Analysis & Trends

Gossamer Bio has reported EBT Margin for 3 years, with the latest figure at 308.63% in Q2 2026.

  • On a quarterly basis, EBT Margin rose 2450.0% year-over-year to 308.63% in Q2 2026; TTM through Jun 2026 was 321.52%, a 3862.0% increase from a year earlier, with the FY2025 full-year figure at 351.67%, down 30317.0% from the prior year.
  • EBT Margin was 308.63% for Q2 2026 at Gossamer Bio, down from 278.78% in the prior quarter.
  • The five-year high for EBT Margin was 56.0% in Q2 2024, with the low at 397.03% in Q1 2025.
  • Average EBT Margin over 3 years is 298.0%, with a median of 336.87% recorded in 2024.
  • The sharpest annual moves came in 2025 and 2026: EBT Margin tumbled 38912 bps in 2025, then jumped 11825 bps in 2026.
  • Over 3 years, EBT Margin stood at 377.85% in 2024, then grew by 9 bps to 342.97% in 2025, then grew by 10 bps to 308.63% in 2026.
  • The last three EBT Margin figures came in at 308.63% (Q2 2026), 278.78% (Q1 2026), and 342.97% (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 26.66%
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 25.18%
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn -4.11%
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn 29.63%
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn -4.34%
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn 12.17%
7 Revolution Medicines 45.00 Bn 45.00 Bn - -
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn 44.89%
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn 47.58%
10 Gossamer Bio 57.60 Mn 576,568.19 - -308.63%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -308.63%
Mar 31, 2026 -278.78%
Dec 31, 2025 -342.97%
Sep 30, 2025 -362.73%
Jun 30, 2025 -333.13%
Mar 31, 2025 -397.03%
Dec 31, 2024 -377.85%
Sep 30, 2024 -336.87%
Jun 30, 2024 56.00%